We’re here to help with coverage, financial, and educational resource needs. Call 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET

We’re here to help with coverage, financial, and educational resource needs. Call 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET

Menu

Global Menu Patient Fruzaqla

Getting Started
Financial Assistance
Frequently Asked Questions
Resources
Enroll

This site is intended for US patients only.

ALUNBRIG® (brigatinib) FRUZAQLA® (fruquintinib) ICLUSIG® (ponatinib) MIMRYLO™ (rusfertide) NINLARO® (ixazomib)

Global Submenu Patient Fruzaqla

Go to Healthcare Professional Site
Go to fruzaqla.com
Recursos en español
Stay Connected

This site is intended for US patients only.

ALUNBRIG® (brigatinib) FRUZAQLA® (fruquintinib) ICLUSIG® (ponatinib) MIMRYLO™ (rusfertide) NINLARO® (ixazomib)

Global Submenu Patient Fruzaqla

Go to Healthcare Professional Site
Go to fruzaqla.com
Recursos en español
Stay Connected

Global Menu Patient Fruzaqla

Getting Started
Financial Assistance
Frequently Asked Questions
Resources
Enroll

Back

Family Support

Preparing for a Doctor’s Appointment

Tips for communicating with your oncologist during your appointment.

Read more

Healthcare provider writing on a chart

The site you are about to enter is not owned or controlled by Takeda

Takeda makes no representation as to the accuracy of the information contained on websites we do not own or control. Takeda does not recommend or endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Continue

The site you are about to enter is intended for US healthcare professionals only.

Please confirm that you are a US healthcare professional.

Yes, I confirm that I am a US healthcare professional

The site you are about to enter is not owned or controlled by Takeda

Takeda makes no representation as to the accuracy of the information contained on websites we do not own or control. Takeda does not recommend or endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Cancel Continue

The site you are about to enter is intended for US healthcare professionals only.

Please confirm that you are a US healthcare professional.

No, I am not a US healthcare professional Yes, I confirm that I am a US healthcare professional

We’re here to help with coverage, financial, and educational resource needs.

We’re here to help with coverage, financial, and educational resource needs.

Call 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET

Call 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET

Please see full Prescribing Information for

ALUNBRIG®, FRUZAQLA®, MIMRYLO™, and

NINLARO®. Please see ICLUSIG® full Prescribing

Information, including Boxed Warning.

Please see full Prescribing Information for ALUNBRIG®, FRUZAQLA®, MIMRYLO™, and NINLARO®. Please see ICLUSIG® full Prescribing Information, including Boxed Warning.

Menu Footer

Terms of Use
Privacy Policy
Contact Us
Site Map

TAKEDA and are registered trademarks of Takeda Pharmaceutical Company Limited. NINLARO, , HERE2ASSIST, and are registered trademarks of Millennium Pharmaceuticals, Inc. ALUNBRIG, , ICLUSIG, and are registered trademarks of ARIAD Pharmaceuticals, Inc. FRUZAQLA and are trademarks of HUTCHMED Group Enterprises Limited, used under license. MIMRYLO and are trademarks of Takeda Pharmaceutical Company Limited. ©2026 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved. 05/26 US-XMP-0435

TAKEDA and are registered trademarks of Takeda Pharmaceutical Company Limited. NINLARO, ,
HERE2ASSIST, and are registered trademarks of Millennium Pharmaceuticals, Inc. ALUNBRIG, , ICLUSIG,
and are registered trademarks of ARIAD Pharmaceuticals, Inc. FRUZAQLA and are trademarks of
HUTCHMED Group Enterprises Limited, used under license. MIMRYLO and are trademarks of Takeda
Pharmaceutical Company Limited.
©2026 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved. 05/26 US-XMP-0435